{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:16:31Z","timestamp":1793337391937,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/50006\/2025"],"award-info":[{"award-number":["UID\/50006\/2025"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006111","name":"Minist\u00e9rio da Ci\u00eancia, Tecnologia e Ensino Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007689","name":"Universidade de Aveiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018886","name":"Laborat\u00f3rio Associado para a Qu\u00edmica Verde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119032","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:39:59Z","timestamp":1780382399000},"page":"119032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recent advancements in 1,2,3-triazole-based derivatives as antidiabetic agents: Synthesis and biological insights"],"prefix":"10.1016","volume":"316","author":[{"given":"Nuno M.M.","family":"Moura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan T.","family":"Abu-Orabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5495-5126","authenticated-orcid":false,"given":"Jos\u00e9 A.S.","family":"Cavaleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119032_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075681","article-title":"New advances in type 1 diabetes","volume":"384","author":"Subramanian","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ejmech.2026.119032_bib2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00125-025-06462-y","article-title":"The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment\u20142024 diabetes, diabetes care, and diabetologia expert Forum","volume":"68","author":"Evans-Molina","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2026.119032_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41574-025-01157-1","article-title":"Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization","volume":"21","author":"Idrees","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.119032_bib4","article-title":"A comprehensive review of emerging therapies for type 2 diabetes and their cardiovascular effects","volume":"29","author":"Acosta G","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2026.119032_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejmech.2026.119032_bib6","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00125-025-06504-5","article-title":"Global challenges in diabetes research and care: which way forward? An appraisal from the EASD global council","volume":"68","author":"Giorgino","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2026.119032_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overview","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2026.119032_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129241","article-title":"Metformin, a biological and synthetic overview","volume":"86","author":"Hern\u00e1ndez-Vel\u00e1zquez","year":"2023","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119032_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.132378","article-title":"An overview of the synthetic routes to essential oral anti-diabetes drugs","volume":"96","author":"Sagandira","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2026.119032_bib10","article-title":"Synthesis and in vivo evaluation of fluorobenzyl metformin derivatives as potential drugs in the diabetes treatment","volume":"12","author":"Hern\u00e1ndez\u2010Vel\u00e1zquez","year":"2023","journal-title":"Asian J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib11","doi-asserted-by":"crossref","DOI":"10.25259\/AJC_80_2025","article-title":"Triazoles- A paradigm shift in drug discovery: a review on synthesis and therapeutic potential","volume":"18","author":"Farwa","year":"2025","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111700","article-title":"1,2,3-Triazole-containing hybrids as potential anticancer agents: current developments, action mechanisms and structure-activity relationships","volume":"183","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib13","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00044-018-2146-4","article-title":"Evaluation of triazole and isoxazole derivatives as potential anti-infective agents","volume":"27","author":"Tarawneh","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2026.119032_bib14","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/molecules25071662","article-title":"Azides and porphyrinoids: synthetic approaches and applications. Part 1\u2014Azides, porphyrins and corroles","volume":"25","author":"Ara\u00fajo","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119032_bib15","series-title":"Organic Azides","first-page":"53","article-title":"Synthesis of azides","author":"Pinho e Melo","year":"2009"},{"key":"10.1016\/j.ejmech.2026.119032_bib16","series-title":"Organic Azides","first-page":"29","article-title":"Large\u2010scale preparation and usage of azides","author":"Haase","year":"2009"},{"key":"10.1016\/j.ejmech.2026.119032_bib17","series-title":"Organic Azides","first-page":"269","article-title":"Cycloaddition reactions with azides: an overview","author":"Schilling","year":"2009"},{"key":"10.1016\/j.ejmech.2026.119032_bib18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2533\/000942904777677605","article-title":"The synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (tamiflu\u00ae): a challenge for synthesis & process research","volume":"58","author":"Abrecht","year":"2004","journal-title":"Chimia"},{"key":"10.1016\/j.ejmech.2026.119032_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/anie.196306331","article-title":"Kinetics and mechanism of 1,3\u2010Dipolar cycloadditions","volume":"2","author":"Huisgen","year":"1963","journal-title":"Angew. Chemie Int. Ed. English"},{"key":"10.1016\/j.ejmech.2026.119032_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/anie.196803211","article-title":"Cycloadditions \u2014 definition, classification, and characterization","volume":"7","author":"Huisgen","year":"1968","journal-title":"Angew. Chemie Int. Ed. English"},{"key":"10.1016\/j.ejmech.2026.119032_bib21","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/jo011148j","article-title":"Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific Copper(I)-Catalyzed 1,3-Dipolar cycloadditions of terminal alkynes to azides","volume":"67","author":"Torn\u00f8e","year":"2002","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib22","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1002\/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0","article-title":"A stepwise huisgen cycloaddition process: copper(i)-catalyzed regioselective \u201cligation\u201d of azides and terminal alkynes","volume":"114","author":"Rostovtsev","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2026.119032_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ejoc.202400113","article-title":"Recent developments in the ruthenium\u2010catalyzed azide alkyne cycloaddition (RuAAC) reaction","volume":"27","author":"Ferrara","year":"2024","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib24","doi-asserted-by":"crossref","first-page":"14726","DOI":"10.1021\/acs.chemrev.6b00466","article-title":"Ruthenium-catalyzed azide alkyne cycloaddition reaction: scope, mechanism, and applications","volume":"116","author":"Johansson","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119032_bib25","series-title":"Compr. Heterocycl. Chem. IV","first-page":"1","article-title":"1,2,3-Triazoles","author":"Moura","year":"2022"},{"key":"10.1016\/j.ejmech.2026.119032_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129927","article-title":"Recent advances in triazole synthesis via click chemistry and their pharmacological applications: a review","volume":"112","author":"Khandelwal","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119032_bib27","doi-asserted-by":"crossref","DOI":"10.1080\/17518253.2024.2307989","article-title":"Biological importance and synthesis of 1,2,3-triazole derivatives: a review","volume":"17","author":"Vaishnani","year":"2024","journal-title":"Green Chem. Lett. Rev."},{"key":"10.1016\/j.ejmech.2026.119032_bib28","doi-asserted-by":"crossref","DOI":"10.2174\/0113895575410016251214175524","article-title":"Development of triazole based anticonvulsants through various catalytic approaches","volume":"26","author":"Rani","year":"2026","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib29","article-title":"Synthesis of 1,2,3-Triazole derivatives using organocatalysts: a review","volume":"30","author":"Dung","year":"2026","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib30","article-title":"1,2,3-Triazole: an important scaffold in drug design and development, heterocycl","volume":"32","author":"Alghamdi","year":"2026","journal-title":"Commun. Now."},{"key":"10.1016\/j.ejmech.2026.119032_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117614","article-title":"1,5-Disubstituted 1,2,3-triazoles: molecular scaffolds for medicinal chemistry and biomolecular mimetics","volume":"291","author":"Mishra","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib32","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1021\/jm901265h","article-title":"Synthesis, biological activity, and molecular modeling studies of 1 H -1,2,3-Triazole derivatives of carbohydrates as \u03b1-Glucosidases inhibitors","volume":"53","author":"Ferreira","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.carres.2012.09.020","article-title":"Synthesis of 1,2,3-triazoles from xylosyl and 5-thioxylosyl azides: evaluation of the xylose scaffold for the design of potential glycogen phosphorylase inhibitors","volume":"364","author":"Goyard","year":"2012","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2026.119032_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bioorg.2017.03.006","article-title":"Synthesis, in vitro evaluation and molecular docking studies of novel amide linked triazolyl glycoconjugates as new inhibitors of alpha-glucosidase","volume":"72","author":"Gupta","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500263","article-title":"Adamantane\u2010appended 1,2,3\u2010Triazole hybrids: Synthesis and \u03b1\u2010Glucosidase inhibition studies through experimental and in silico approach","volume":"20","author":"Ragshaniya","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119032_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2018.08.008","article-title":"Synthesis of 1H-1,2,3-triazole derivatives as new \u03b1-glucosidase inhibitors and their molecular docking studies","volume":"81","author":"Avula","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103182","article-title":"Synthesis of novel (R)-4-fluorophenyl-1H-1,2,3-triazoles: a new class of \u03b1-glucosidase inhibitors","volume":"91","author":"Avula","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115861","article-title":"Synthesis, in vitro evaluation, and computational simulations studies of 1,2,3-triazole analogues as DPP-4 inhibitors","volume":"29","author":"Vo","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70088","article-title":"Development of 1,2,3\u2010Triazoles as dual enzyme inhibitors targeting \u03b1\u2010Amylase and \u03b1\u2010Glucosidase for type 2 diabetes intervention","volume":"358","author":"Sruthi","year":"2025","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119032_bib40","doi-asserted-by":"crossref","first-page":"8960","DOI":"10.1038\/s41598-023-36046-y","article-title":"Novel N\u2032-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent \u03b1-glucosidase inhibitors","volume":"13","author":"Saeedi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119032_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900034","article-title":"A new series of schiff base derivatives bearing 1,2,3\u2010triazole: design, synthesis, molecular docking, and \u03b1\u2010glucosidase inhibition","volume":"352","author":"Nasli\u2010Esfahani","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119032_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molstruc.2019.04.082","article-title":"New thiosemicarbazide-1,2,3-triazole hybrids as potent \u03b1-glucosidase inhibitors: design, synthesis, and biological evaluation","volume":"1192","author":"Bakherad","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128745","article-title":"Design, synthesis and anti-diabetic activity of novel 1,2,3-triazole-5-carboximidamide derivatives as dipeptidyl peptidase-4 inhibitors","volume":"1221","author":"Dastjerdi","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib44","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/molecules28073104","article-title":"Designing click one-pot synthesis and antidiabetic studies of 1,2,3-Triazole derivatives","volume":"28","author":"Shafique","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119032_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202502778","article-title":"1,2,3\u2010triazole\u2010aminobenzoates: design, synthesis, in vitro antidiabetic and anti\u2010alzheimer activities, molecular docking, and ADME properties","volume":"10","author":"\u015euekinci Y\u0131lmaz","year":"2025","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119032_bib46","doi-asserted-by":"crossref","first-page":"35509","DOI":"10.1039\/D5RA06028A","article-title":"Recent advances in non-conventional synthesis of N-heterocyclic compounds: emerging strategies and biological perspectives","volume":"15","author":"Sivaraj","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119032_bib47","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1021\/acs.jmedchem.4c01122","article-title":"An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved pharmaceuticals (2013\u20132023)","volume":"67","author":"Marshall","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103056","article-title":"Synthesis, anti-diabetic evaluation and molecular docking studies of 4-(1-aryl-1H-1, 2, 3-triazol-4-yl)-1,4-dihydropyridine derivatives as novel 11-\u03b2 hydroxysteroid dehydrogenase-1 (11\u03b2-HSD1) inhibitors","volume":"90","author":"Praveenkumar","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib49","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.53730\/ijhs.v6nS4.10171","article-title":"Synthesis and anti-diabetic activity evaluation of new 1,2,3-triazole derivatives incorporating 2-pyrazoline ring","author":"Mazyed","year":"2022","journal-title":"Int. J. Health Sci."},{"key":"10.1016\/j.ejmech.2026.119032_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128253","article-title":"Synthesis, characterization, \u03b1-glucosidase inhibition and molecular modeling studies of some pyrazoline-1H-1,2,3-triazole hybrids","volume":"1216","author":"Kumar","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203578","article-title":"Synthesis of pyrazoline\u2010embedded 1,2,3\u2010Triazole derivatives via 1,3\u2010Dipolar cycloaddition reactions with in vitro and in silico studies","volume":"8","author":"Banu","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2026.119032_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106750","article-title":"Design, synthesis and antidiabetic study of triazole clubbed indole derivatives as \u03b1-glucosidase inhibitors","volume":"139","author":"Ritu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-66201-y","article-title":"Design, synthesis, in vitro, and in silico anti-\u03b1-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents","volume":"14","author":"Sayahi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119032_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144858","article-title":"Semi-synthesis of new 1,2,3-triazoles linked to harmine isolated from Peganum harmala seeds, anti-\u03b1-amylase activity, molecular docking, ADMET profiling, and DFT study","volume":"1354","author":"Khemis","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.jics.2025.102215","article-title":"Synthesis of spirooxindole-pyrazoline clubbed 1,2,3-triazoles as \u03b1-glucosidase inhibitors: experimental and computational studies","volume":"102","author":"Bhukal","year":"2025","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119032_bib56","article-title":"Design, synthesis and alpha\u2010glucosidase inhibitory effect of Pyrazole\u20101,2,3\u2010Triazole hybrids","volume":"22","author":"Sirisha","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119032_bib57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00706-021-02779-7","article-title":"New 4,5-diphenylimidazole-acetamide-1,2,3-triazole hybrids as potent \u03b1-glucosidase inhibitors: synthesis, in vitro and in silico enzymatic and toxicity evaluations","volume":"152","author":"Sepehri","year":"2021","journal-title":"Monatshefte F\u00fcr Chemie - Chem. Mon."},{"key":"10.1016\/j.ejmech.2026.119032_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39424-8","article-title":"Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting \u03b1-glucosidase","volume":"13","author":"Yousefnejad","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119032_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000090","article-title":"Synthesis and antidiabetic evaluation of benzimidazole\u2010tethered 1,2,3\u2010triazoles","volume":"353","author":"Deswal","year":"2020","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2026.119032_bib60","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11164-022-04921-4","article-title":"Benzimidazole-1,2,3-triazole-piperazine hybrids: design, synthesis, antidiabetic evaluation and molecular modelling studies","volume":"49","author":"Deswal","year":"2023","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2026.119032_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22091555","article-title":"Synthesis, in vitro alpha-Glucosidase inhibitory activity and molecular docking studies of novel benzothiazole-triazole derivatives","volume":"22","author":"Gong","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119032_bib62","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s11030-021-10310-7","article-title":"Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as \u03b1-glycosidase inhibitors","volume":"26","author":"Nasli Esfahani","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119032_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-36890-y","article-title":"Design, synthesis, in vitro anti-\u03b1-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents","volume":"13","author":"Emadi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119032_bib64","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1002\/jhet.4142","article-title":"Design, synthesis, biological evaluation, and docking study of new acridine\u20109\u2010carboxamide linked to 1,2,3\u2010triazole derivatives as antidiabetic agents targeting \u03b1\u2010glucosidase","volume":"57","author":"Asgari","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144841","article-title":"Quinoline-1,2,3-triazole hybrids as dual inhibitors of \u03b1-glucosidase and \u03b1-amylase: synthesis, in vitro evaluation, and structure-activity relationship studies","volume":"1354","author":"Surapaneni","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.103851","article-title":"Greener pastures in evaluating antidiabetic drug for a quinoxaline derivative: synthesis, characterization, molecular docking, in vitro and HSA\/DFT\/XRD studies","volume":"15","author":"Missioui","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bioorg.2018.10.023","article-title":"Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro \u03b1-glucosidase inhibition, kinetic, and docking study","volume":"83","author":"Saeedi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib68","doi-asserted-by":"crossref","DOI":"10.24820\/ark.5550190.p012.403","article-title":"Synthesis, characterization and biological evaluation of 1-(1H-1,2,3- triazol-4-yl)methyl)-1-pyrazolo[3,4-b]quinoline derivatives","volume":"2025","author":"Ntshele","year":"2025","journal-title":"ARKIVOC (Gainesville, FL, U. S.)"},{"key":"10.1016\/j.ejmech.2026.119032_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202402381","article-title":"Design, synthesis, in silico and in vitro dipeptidyl Peptidase\u20104 activity of triazole\u2010based heterocyclic compounds","volume":"22","author":"Kumar","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.119032_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142599","article-title":"Designing DPP-4 inhibitors: synthesis, characterization, in silico & in vitro evaluation, and theoretical calculation of flexible compounds linked via ortho xylyl spacers","volume":"1341","author":"Kumar","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib71","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cmdc.201800119","article-title":"The current status of O\u2010heterocycles: a synthetic and medicinal overview","volume":"13","author":"Singh","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119032_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103206","article-title":"Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: design, synthesis, in vitro \u03b1-glucosidase inhibition, kinetic, and docking studies","volume":"92","author":"Asgari","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135493","article-title":"Design and synthesis of novel 1,2,3-triazole linked hybrids: molecular docking, MD simulation, and their antidiabetic efficacy as \u03b1-Amylase inhibitors","volume":"1285","author":"Zala","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135194","article-title":"Development of coumarin tagged 1,2,3-triazole derivatives targeting \u03b1-glucosidase inhibition: synthetic modification, biological evaluation, kinetic and in silico studies","volume":"1282","author":"Khouzani","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib75","doi-asserted-by":"crossref","first-page":"51136","DOI":"10.1039\/D5RA07254A","article-title":"New coumarin\u2013chalcone\u2013triazole hybrids as promising anti-diabetic agents: from molecular design to in vivo validation","volume":"15","author":"Peytam","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2026.119032_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106028","article-title":"Flavone-1,2,3-triazole derivatives as potential \u03b1-glucosidase inhibitors: synthesis, enzyme inhibition, kinetic analysis and molecular docking study","volume":"127","author":"Dhameja","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib77","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ejmech.2019.05.045","article-title":"Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: \u03b1-Glucosidase inhibition and glucose uptake promotion","volume":"177","author":"Ye","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib78","doi-asserted-by":"crossref","first-page":"24901","DOI":"10.1021\/acsomega.3c01291","article-title":"Meldrum-Based-1 H -1,2,3-Triazoles as antidiabetic agents: synthesis, in vitro \u03b1-Glucosidase inhibition activity, molecular docking studies, and in silico approach","volume":"8","author":"Avula","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119032_bib79","doi-asserted-by":"crossref","first-page":"23412","DOI":"10.1021\/acsomega.3c00133","article-title":"Novel Pyrano[3,2-c]quinoline-1,2,3-triazole hybrids as potential anti-diabetic agents: in vitro \u03b1-Glucosidase inhibition, kinetic, and molecular dynamics simulation","volume":"8","author":"Esmaili","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2026.119032_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107363","article-title":"Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: exploring their utility in the development of antidiabetic drugs via inhibition of \u03b1-amylase and DPP4 activity","volume":"147","author":"Chahal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib81","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1134\/S1070363223040199","article-title":"Mechanochemical synthesis of thiazolidinone-triazoles derivatives as antidiabetic agents: pharmacokinetics, molecular docking, and in vitro antidiabetic properties","volume":"93","author":"Taj","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib82","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1038\/s41598-025-88944-y","article-title":"CADD based designing and biological evaluation of novel triazole based thiazolidinedione coumarin hybrids as antidiabetic agent","volume":"15","author":"Sharma","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119032_bib83","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s11030-023-10674-y","article-title":"Synthesis, antidiabetic activity and molecular docking studies of novel aryl benzylidenethiazolidine-2,4-dione based 1,2,3-triazoles","volume":"28","author":"Patnam","year":"2024","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119032_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143567","article-title":"Design, synthesis, and multi-target biological evaluation of 1,2,3-triazole linked indole\u2013thiazolidinedione hybrids as potent \u03b1-glucosidase, \u03b1-amylase, and DPP-4 inhibitors with antioxidant potential","volume":"1349","author":"Sharma","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2026.119032_bib85","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1039\/D2NJ05059E","article-title":"Thiazolidine-2,4-dione framework containing spiropyrrolidine-oxindole and 1,2,3-triazole scaffold: synthesis, in vitro \u03b1-amylase inhibition and in silico studies","volume":"47","author":"Duhan","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2026.119032_bib86","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s13738-025-03276-y","article-title":"Design and evaluation of pyridine-linked 1,3,4-oxadiazole-triazole heterocycles: a synthetic, computational and biological study","volume":"22","author":"Poojary","year":"2025","journal-title":"J. Iran. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.119032_bib87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.mie.2020.09.012","article-title":"Predicting the effect of disordered linkers on effective concentrations and avidity with the \u201cC calculator\u201d app","volume":"647","author":"Kjaergaard","year":"2021","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2026.119032_bib88","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/j.apsb.2024.04.007","article-title":"Characteristic roadmap of linker governs the rational design of PROTACs","volume":"14","author":"Dong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119032_bib89","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1021\/acs.jmedchem.3c00134","article-title":"Macrocycles in drug discovery\u2500learning from the past for the future","volume":"66","author":"Garcia Jimenez","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:13:26Z","timestamp":1783923206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":89,"alternative-id":["S0223523426004770"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119032","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advancements in 1,2,3-triazole-based derivatives as antidiabetic agents: Synthesis and biological insights","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119032"}}